Problem
Research questions and friction points this paper is trying to address.
adaptive deep brain stimulation
Parkinson's disease
neuromorphic silicon neuron
low-power implantable circuits
beta-band suppression
Neuromorphic Silicon Neuron Controller for Adaptive Deep Brain Stimulation in Parkinson's Disease
🤖 AI Summary
This study addresses the high power consumption and integration challenges of existing adaptive deep brain stimulation (aDBS) systems for long-term Parkinson’s disease treatment by proposing a neuromorphic hardware solution. The authors present SiLIF-DBS, a CMOS-based silicon neuron controller that implements a leaky integrate-and-fire (LIF) neuron model in hardware for the first time. Using the average rectified value of beta-band subthalamic nucleus local field potentials (STN-LFPs) as a biomarker, SiLIF-DBS enables closed-loop adaptive stimulation. The system achieves a 75% reduction in power consumption compared to open-loop stimulation while delivering a beta oscillation suppression efficiency of 5.85%/μW, demonstrating its potential as a low-power, implantable aDBS platform capable of effectively suppressing pathological neural activity.
📝 Abstract
Parkinson's disease (PD) affects millions worldwide and causes severe motor symptoms. Adaptive deep brain stimulation (aDBS) delivers physiologically informed stimulation that can track fluctuations in PD motor symptoms, enabling more intelligent DBS control. However, most existing aDBS approaches are primarily algorithm- and software-driven, with limited efforts toward circuit realization, particularly low-power and implantable integrated circuits. This paper presents the Silicon Leaky Integrate-and-Fire Deep Brain Stimulation (SiLIF-DBS) controller, a neuromorphic silicon neuron stimulator implemented with metal-oxide-semiconductor (CMOS) technology. For system-level evaluation, a simplified computational model of the SiLIF-DBS controller is derived and embedded within a Parkinsonian cortico-basal ganglia framework for closed-loop validation. The system is driven by beta-band subthalamic nucleus local field potentials (STN-LFPs), with their average rectified value (Beta ARV) used as the control biomarker. Our SiLIF-DBS controller for aDBS suppresses pathological beta activity while consuming only 25% of the power required by open-loop stimulation and achieving a suppression efficiency of $5.85\%$/$μ$W. Overall, our SiLIF-DBS controller achieves strong beta suppression at substantially reduced power, delivering high suppression efficiency that demonstrates it is a viable foundation for low-power implantable aDBS.
Innovation
Methods, ideas, or system contributions that make the work stand out.
neuromorphic engineering
adaptive deep brain stimulation
SiLIF neuron
low-power CMOS
beta-band biomarker
🔎 Similar Papers
No similar papers found.
